Immunophage is Drug Discovery in China that focus on disease therapeutics business. Founded in 2016. They cover business area such as developer, cancer, autoimmune disease, neurodegenerative disease therapeutic, tumor growth, Myeloid-derive suppressor cell production, multi-faceted treatment, healthcare professional, more effective treatment, their patient.
2016
( 8 years old in 2024 )
Disease Therapeutics
-
Building 16, Tree House, No. 73 Tan Mi Road
Jiangbei New District
Nanjing, Jiangsu
China
Private
developercancerautoimmune diseaseneurodegenerative disease therapeutictumor growthMyeloid-derive suppressor cell productionmulti-faceted treatmenthealthcare professionalmore effective treatmenttheir patient
* We use standard office opening hours in near Immunophage's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Immunophage is Drug Discovery business from China that founded in 2016 (8 years old in 2024), Immunophage business is focusing on Disease Therapeutics.
Immunophage headquarter office and corporate office address is located in Building 16, Tree House, No. 73 Tan Mi Road Jiangbei New District Nanjing, Jiangsu China.
Immunophage was founded in China.
In 2024, Immunophage is currently focus on disease therapeutics sector.
Above is snippet of Google Trends for "disease therapeutics" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Immunophage, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
